Head and Neck surgeonMelanoma Institute Australia, United States
63: An Externally Validated Online Tool To Calculate Personalized Probabilities Of Recurrence-Free And Overall-Survival In Stage II Melanoma Patients.
Thursday, March 21, 20242:27pm – 2:37pm ET
59: Surgical considerations for resecting the index lymph node after neo-adjuvant checkpoint inhibitors: lessons learned from the PRADO trial
Friday, March 22, 20242:02pm – 2:14pm ET
